✦ LIBER ✦

Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy

✍ Scribed by Hans Brincker; Gunnar Saeter

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 556 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860315)57:6<1124::aid-cncr2820570611>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Totally implanted device for long-term i

Totally implanted device for long-term intravenous chemotherapy: Experience in 123 adult patients with solid neoplasms

✍ Puig-la Calle, Jorge; López Sánchez, Santos; Piedrafita Serra, Encarnación; Hono 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Vascular access in patients receiving prolonged chemotherapy is a difficult problem. This led to the introduction of a totally implanted device. We intend to assess the efficacy of this device in a subset of oncologic patients. Between May 1989 and November 1992, 129 devices were placed in 123 adult

Long-term experience with a totally impl

Long-term experience with a totally implanted catheter system in cancer patients

✍ Cesar O. Freytes; Patricia Reid; Kirby L. Smith 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

Camp chemotherapy for metastatic non-oat

Camp chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975–1981) with 160 patients

✍ Kirk V. Shepard; Harvey M. Golomb; Jacob D. Bitran; Philip C. Hoffman; Steven B. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

A new site for totally implanted central

A new site for totally implanted central venous access system in patients with malignancy: Long-term results of 10 cases

✍ P. Appelqvist; P. Pantzar 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

In this study of 10 patients with central venous access system, the reservoir body was implanted in the lower limb. Only one complication was observed per 1,560 days of function time. The anterolateral distal half of the thigh is a good alternative site for the injection port in cancer patients whos

Prognostic factors for osteosarcoma of t

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy : 15-year experience in 789 patients treated at a single institution

✍ Gaetano Bacci; Alessandra Longhi; Michela Versari; Mario Mercuri; Antonio Bricco 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views